Insider Transactions Reported by 17 Insiders of Fusion Pharmaceuticals Inc.

Location
Hamilton, Ontario, Canada

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Fusion Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Valliant Chief Executive Officer, Director $390,166 04 Jun 2024
Mohit Rawat President & CBO $191,110 04 Jun 2024
James J. O'Leary Chief Medical Officer $4,105 01 Feb 2022
Dmitri Bobilev Chief Medical Officer $0 04 Jun 2024
John J. Crowley Chief Financial Officer $0 04 Jun 2024
Eric Burak Chief Technology Officer $0 04 Jun 2024
Christopher P. Leamon Chief Scientific Officer $0 04 Jun 2024
David D. Meek Director 04 Jun 2024
Jeremy Bender Director 04 Jun 2024
Teresa Marie Bitetti Director 04 Jun 2024
Philina Lee Director 04 Jun 2024
STEVEN GANNON Director 04 Jun 2024
Heather Preston Director 14 Jun 2023
Chau Quang Khuong Director 14 Jun 2023
Barbara Gayle Duncan Director 04 Jun 2024
Donald A. Bergstrom Director 04 Jun 2024
PABLO J. CAGNONI Director 04 Jun 2024

Recent Insider Transactions by Companies or Individuals for Fusion Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.